Mouse
in vivo PD-L1 blockade, in vitro PD-L1 blockade, IF, IHC-F, FCM, WB
Rat
Monoclonal
IgG2b kappa
10F.9G2
Human
FCM, Isotype Control, In vivo Control
Human
Monoclonal
IgD kappa
HyHEL-10
Mouse
in vivo IL-6 neutralization, in vitro IL-10 neutralization
Rat
Monoclonal
IgG1 kappa
MP5-20F3
Mouse
in vivo IFNγ neutralization, in vitro IFNγ neutralization
Rat
Monoclonal
IgG1 kappa
R4-6A2
Mouse
in vivo blocking of PD-L1/CD80 (B7-1) interactions, in vitro blocking of PD-L1/CD80 (B7-1) interactions, ELISA, FCM
Rat
Monoclonal
IgG2b kappa
10F.2H11
Human, Mouse
in vivo CD44 neutralization, in vitro CD44 neutralization
Rat
Monoclonal
IgG2b kappa
IM7
Mouse
in vivo VEGF-A neutralization, in vitro VEGF-A neutralization, WB
Rat
Monoclonal
IgG2a kappa
2G11-2A05
Mouse
in vivo Integrin α4β7 neutralization, FCM
Rat
Monoclonal
IgG2a kappa
DATK32
Mouse
in vivo blocking of VEGF/VEGFR-2 signaling, in vitro blocking of VEGFR signaling, WB
Rat
Monoclonal
IgG1 kappa
DC101
Mouse
in vivo TNFα neutralization, in vitro TNFα neutralization, WB
Rat
Monoclonal
IgG1 kappa
XT3.11